SC-41930 [Ligand Id: 6156] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL14823 (SC-41930)
  • BLT1 receptor/Leukotriene B4 receptor 1 in Human [ChEMBL: CHEMBL3911] [GtoPdb: 267] [UniProtKB: Q15722]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
BLT1 receptor/Leukotriene B4 receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3911] [GtoPdb: 267] [UniProtKB: Q15722]
ChEMBL In vitro antagonist activity against leukotriene B4 (LTB4) receptor in [3H]-LTB4 human neutrophil receptor binding assay B 6.55 pKi 280 nM Ki Bioorg Med Chem Lett (1995) 5: 887-892
ChEMBL Binding affinity against Leukotriene B4 receptor on intact differentiated U-937 cells in competitive binding assay with [3H]LTB4 B 6.66 pKi 220 nM Ki J Med Chem (1993) 36: 3333-3340 [PMID:8230123]
GtoPdb - - 7.77 pKi 17 nM Ki Biochem Pharmacol (1995) 49: 1683-90 [PMID:7786309]
GtoPdb - - 6.1 pIC50 808 nM IC50 Biochem Pharmacol (1995) 49: 1683-90 [PMID:7786309]
ChEMBL Binding affinity for Leukotriene B4 (LTB4) receptor B 6.49 pIC50 320 nM IC50 J Med Chem (1995) 38: 858-868 [PMID:7699700]
ChEMBL Concentration inhibiting the binding of [3H]LTB4 to human neutrophils B 6.52 pIC50 300 nM IC50 J Med Chem (1992) 35: 4253-4255 [PMID:1331462]
ChEMBL Inhibitory concentration against leukotriene receptor B4 (LTB4) in human polymorphonuclear cells (PMNs) B 6.52 pIC50 300 nM IC50 J Med Chem (1993) 36: 2703-2705 [PMID:8410983]
ChEMBL Compound was evaluated in a human neutrophil leukotriene B4 receptor binding assay B 6.52 pIC50 300 nM IC50 J Med Chem (1989) 32: 1145-1147 [PMID:2542550]
ChEMBL In vitro inhibitory activity against human neutrophil leukotriene B4 (LTB4) induced Chemotaxis F 6.85 pIC50 140 nM IC50 Bioorg Med Chem Lett (1995) 5: 887-892
ChEMBL Binding affinity towards Leukotriene B4 (LTB4) Receptor. (Experiment conducted in the absence of NDGA) B 7.37 pIC50 43 nM IC50 J Med Chem (1995) 38: 858-868 [PMID:7699700]
ChEMBL Compound was tested for inhibitory activity against LTB4 (leukotriene) binding B 7.7 pIC50 20 nM IC50 J Med Chem (1996) 39: 2629-2654 [PMID:8709092]
ChEMBL Inhibitory activity against leukotriene B4 receptor B 9 pIC50 1 nM IC50 Bioorg Med Chem Lett (1994) 4: 811-816

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]